Viewing Study NCT02722668


Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2026-02-25 @ 9:47 PM
Study NCT ID: NCT02722668
Status: COMPLETED
Last Update Posted: 2025-07-04
First Post: 2016-03-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
Sponsor: Masonic Cancer Center, University of Minnesota
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Leukemia View
None Acute Myeloid Leukemia View
None Acute Lymphoblastic Leukemia/Lymphoma View
None Burkitt's Lymphoma View
None Natural Killer Cell Malignancies View
None Chronic Myelogenous Leukemia View
None Myelodysplastic Syndrome View
None Large-cell Lymphoma View
None Hodgkin Lymphoma View
None Multiple Myeloma View
None Relapsed Chronic Lymphocytic Leukemia View
None Relapsed Small Lymphocytic Lymphoma View
None Marginal Zone B-cell Lymphoma View
None Follicular Lymphoma View
None Lymphoplasmacytic Lymphoma View
None Mantle-cell Lymphoma View
None Prolymphocytic Leukemia View
None Bone Marrow Failure Syndromes View
None Myeloproliferative Neoplasms/Myelofibrosis View
None Biphenotypic/Undifferentiated/Prolymphocytic Leukemias View
None MRD Positive Leukemia View
None Leukemia or MDS in Aplasia View
None Relapsed T-Cell Lymphoma View
None Relapsed Multiple Myeloma View
None Plasma Cell Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AML View
None ALL View
None CML View
None CLL View
None SLL View